The Effects of High-flow Nasal Oxygen on Oxygenation During Rigid Bronchoscopy Under General Anesthesia in Pediatric Patients

NCT ID: NCT03905733

Last Updated: 2019-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-30

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the effect of high-flow nasal cannula oxygen administration on maintenance of oxygenation and removal of carbon dioxide during apnoeic period in pediatric patients undergoing general anesthesia with rigid bronchoscopy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Foreign Bodies Tumor Stenosis of Trachea Bronchus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

general anesthesia with rigid bronchoscopy

Patients 7 years or younger who undergo general anesthesia with rigid bronchoscopy

Optiflow

Intervention Type DEVICE

supply of oxygen at 2 L / min/ kg through Optiflow

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Optiflow

supply of oxygen at 2 L / min/ kg through Optiflow

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Patients undergoing general anesthesia with stent placement or bougination, biopsy or removal of a foreign body or a mass through a rigid bronchoscope
* 2\. Patients aged 7 or younger who meet American Society of Anesthesiologists (ASA) physical class 2-4

Exclusion Criteria

* 1\. Patients undergoing extracorporeal membrane oxygenation (ECMO)
* 2\. Patients with active nasal bleeding), severe nasal obstruction, recent nasal trauma of surgery
* 3\. Patients with current maxillofacial trauma or basal skull fracture
* 4\. Patients with active nasal bleeding), severe nasal obstruction, recent nasal trauma of surgery
* 5\. Extremely low birth weight infant and premature infant less than 28 weeks gestation age
* 6\. Patients who had previously undergone rigid bronchoscopy / surgery
* 7\. If the parent of subject includes a person who can not read the written consent (eg, illiterate, foreigner, etc.)
Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chang Young Lee, MD

Role: primary

82-10-2720-7399

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1-2019-0009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.